Page last updated: 2024-08-26

vinpocetine and Acute Relapsing Multiple Sclerosis

vinpocetine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nakamuro, T; Suzumura, A; Takayanagi, T; Tamaru, T	1

Trials

1 trial(s) available for vinpocetine and Acute Relapsing Multiple Sclerosis

Article	Year
Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors. Multiple sclerosis (Houndmills, Basingstoke, England), 2000, Volume: 6, Issue:1 Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Phosphodiesterase Inhibitors; Pilot Projects; Recurrence; Theophylline; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines	2000

Article

Year

Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors.

Multiple sclerosis (Houndmills, Basingstoke, England), 2000, Volume: 6, Issue:1

Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Phosphodiesterase Inhibitors; Pilot Projects; Recurrence; Theophylline; Treatment Outcome; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines

2000